HomePriority systemsPaw & Nose Care System
Priority system 4 · Conditional on balm capability

Private-label dog paw cleaner foam, paw wipes and paw balm manufacturer

Aimo coordinates paw-cleansing foam, paw wipes and paw or nose balm as a use-case system. The liquid and wipe directions can be scoped first; balm manufacturing, hot/cold stability, leakage and pack compatibility remain conditional until the producing entity and process are confirmed.

Verified role statedEvidence gateNon-medicated laneMOQ boundariesLast verified 11 September 2026
Direct procurement answer

What can a buyer rely on today?

Guangzhou Aimo Pet Products Co., Ltd. is the public brand, commercial and export counterparty. Development offer. Paw/nose balm is not presented as a verified in-house capability; it becomes a commercial offer only after process and evidence approval.

This wording deliberately separates a commercial offer from a factory certificate, completed audit, test result or regulatory approval.

Concept presentation for Paw & Nose Care System private-label project

Project architecture

Offer: paw-cleansing foam + paw wipes + conditional paw/nose balm.

Best-fit buyers: outdoor, winter, travel and everyday pet-care brands.

MOQ rule: Quoted per format. For reference: paw-cleansing foam is expected to follow Aimo’s liquid-line rule of approximately 5,000 units per SKU with a stock foamer bottle once the formula is approved; paw wipes follow the wipe line at approximately 10,000 packs per SKU; paw/nose balm carries no MOQ until the producing process is confirmed.

Sample rule: Separate samples and acceptance criteria are required for foam, wipes and balm. A set is approved only after every format passes its own gate.

Specify the format before asking for a quote

FormatProcurement definition
Paw-cleansing foamNo-rinse or wipe-off direction; foamer compatibility and residue are evaluated.
Paw wipesTextured wipe for post-walk cleaning; strength and lotion loading are use-specific.
Paw balmAnhydrous wax/oil direction in tin or stick; capability and stability are conditional.
Nose balmA separate low-fragrance/unscented brief; do not simply relabel the paw balm.
Claims boundary
  • No healing, repairing cracks, anti-inflammatory or veterinary treatment claim without support.
  • No lick-safe, non-toxic or hypoallergenic absolute claim.
  • No hot-pavement or winter protection claim without defined test/usage evidence.

Evidence pack required before production approval

01 · Producing entity and balm process

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

02 · Full formula and ingredient safety review

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

03 · Hot/cold and accelerated stability

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

04 · Tin/stick/foamer compatibility and leakage

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

05 · Finished-product microbiology where applicable

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

06 · Use instructions and claim substantiation

Confirm subject, issuer/owner, method or scope, date, limitations and whether the item is safe to disclose.

A buyer can review the cross-category status matrix in Aimo’s six-product OEM readiness room. A company statement is not the same as an independent certificate or test report.

Paw-care OEM landscape: who makes foam, wipes and balm, and at what minimum

Public MOQ statements, September 2026. Most suppliers make one of the three formats; very few quote all three. Figures are the suppliers’ own; confirm before budgeting.

SupplierBaseFoam / cleanserPaw wipesPaw or nose balm
AimoGuangzhou, China~5,000 units (liquid line, after formula approval)~10,000 packs (wipe line)conditional development offer, no MOQ yet
Puyan PetChina1,000 units ODM; 2,000 custom formula; 5,000 own formula
Nanjing PetivarChina1,000 pcs no-rinse foam
Wenzhou AodingChina2,000 bottles5,000 pcs
Naturo & OrgoIndia500–1,000 units cleanser1,000 units, 20-day lead
ORIZI GroupMalaysiaquote50 units launch pack; 500 standard
Bo InternationalIndiaquotequote
BiocrownTaiwanquotequote (paw/nose cream)
Cassco Bio LabsUSA“low minimums”2 oz nose & paw balm, no figure
EverionChina5,000 packs
Phoenix WipesUSAquote

How to read it. If the only product is a paw foam, Puyan or Petivar quote lower minimums than Aimo and should be on the shortlist. If the line is a coordinated set (foam plus wipes, later a balm), Aimo is one of very few suppliers that can quote the foam and the wipes on one cost sheet, and it says plainly that the balm is not yet a verified capability rather than listing it as a stock item. Ask every supplier the same three questions: which format is made in-house, whether the MOQ is per SKU or per formula, and what stability data exists for the foamer and the balm in summer transit.

Buyer questions, answered without overclaiming

Can Aimo currently manufacture paw balm?
It is a conditional development offer. Buyers should treat it as unverified until the producing entity, equipment/process, formula and stability evidence are supplied.
Why combine foam, wipes and balm?
They address different steps: remove surface soil, perform quick cleanup and condition after cleaning. A coordinated range can share brand architecture without pretending the formulas are interchangeable.
Is the balm lick-safe?
Absolute safety wording is not used. The exact formula requires ingredient review, exposure assumptions, directions and market-specific label approval.
What packaging needs testing?
Foamer/pump function, wipe seal, balm tin or stick compatibility, leakage, odour transfer and hot/cold transport conditions.
Can one balm serve paws and noses?
Not automatically. Contact pattern, fragrance, hardness and instructions differ, so a separate specification or documented justification is needed.
Which claims should be avoided?
Healing cracks, anti-inflammatory action, pain relief, infection prevention and absolute protection claims unless substantiated and legally reviewed.
Project intake

Send the variables that control feasibility and MOQ

Include target market, product form, annual volume, reference SKU, formula/claim direction, pack size, closure, decoration and desired launch date. Aimo will return a question list and evidence plan before presenting an unsupported factory promise.

[email protected]
+86-150-1420-2977